Seven Fleet Capital Management »

Ascendis Pharma A S shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 5.7k 213.24

More positions owned by Seven Fleet Capital Management

Cg Oncology (CGON)
Soleno Therapeutics (SLNO)
Revolution Medicines (RVMD)
Liquidia Corporation Com New (LQDA)
Compass Therapeutics (CMPX)
Exelixis (EXEL)
Axsome Therapeutics (AXSM)
Tyra Biosciences (TYRA)
Cogent Biosciences (COGT)
Tango Therapeutics (TNGX)
Xencor (XNCR)
Pharvaris N V (PHVS)
Terns Pharmaceuticals (TERN)
Belite Bio Sponsored Ads (BLTE)
Dyne Therapeutics (DYN)

View all positions for Seven Fleet Capital Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Henderson Group
Artisan Partners Limited Partnership
Capital Research and Management Company - Division 3
Franklin Resources
Massachusetts Financial Services
Wellington Management Company
T. Rowe Price Investment Management
American Century Companies
Perceptive Advisors
Principal Financial Group
Susquehanna International

View all funds holding Ascendis Pharma A S